Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Nang Kuang Pharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,737	4,156	5,383	6,453	3,888	3,999
Market Cap Growth	-11.06%	-22.80%	-16.59%	65.97%	-2.78%	-4.74%
Enterprise Value	4,173	4,435	5,681	6,651	4,113	4,240
Last Close Price	37.00	39.35	49.08	56.73	32.52	32.04
PE Ratio	14.57	17.07	27.13	18.33	19.83	21.81
Forward PE	-	17.93	17.93	17.93	17.93	17.93
PS Ratio	1.68	1.89	2.50	3.33	2.18	2.28
PB Ratio	1.54	1.72	2.26	2.68	1.74	1.81
P/TBV Ratio	1.54	1.72	2.27	2.68	1.74	1.82
P/FCF Ratio	1909.35	-	119.36	23.44	9.71	65.70
P/OCF Ratio	7.80	8.91	15.71	17.48	6.99	26.48
EV/Sales Ratio	1.88	2.02	2.64	3.43	2.31	2.42
EV/EBITDA Ratio	8.03	9.01	12.89	13.39	9.49	10.36
EV/EBIT Ratio	12.44	14.30	21.86	20.68	16.16	18.85
EV/FCF Ratio	2132.25	-	125.98	24.16	10.27	69.66
Debt / Equity Ratio	0.29	0.26	0.30	0.17	0.24	0.22
Debt / EBITDA Ratio	1.34	1.29	1.60	0.82	1.23	1.18
Debt / FCF Ratio	356.93	-	15.65	1.49	1.33	7.93
Asset Turnover	0.61	0.57	0.58	0.55	0.53	0.54
Inventory Turnover	1.98	1.97	1.75	1.63	1.61	1.73
Quick Ratio	0.61	0.63	0.59	0.76	0.72	0.68
Current Ratio	1.33	1.27	1.20	1.58	1.39	1.51
Return on Equity (ROE)	10.79%	10.14%	8.29%	15.14%	8.82%	8.35%
Return on Assets (ROA)	5.73%	5.06%	4.37%	5.73%	4.75%	4.29%
Return on Invested Capital (ROIC)	10.14%	9.12%	9.42%	11.56%	8.91%	7.87%
Return on Capital Employed (ROCE)	12.50%	11.60%	10.10%	12.60%	10.80%	9.70%
Earnings Yield	6.88%	5.86%	3.69%	5.46%	5.04%	4.59%
FCF Yield	0.05%	-1.40%	0.84%	4.27%	10.30%	1.52%
Dividend Yield	4.32%	4.07%	4.08%	4.05%	5.54%	5.00%
Payout Ratio	62.86%	82.98%	117.07%	51.64%	82.39%	93.61%
Buyback Yield / Dilution	-0.15%	-0.10%	0.08%	0.01%	-0.03%	-0.82%
Total Shareholder Return	4.18%	3.96%	4.15%	4.06%	5.50%	4.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.